Results 111 to 120 of about 28,392 (204)

Correction: Comparative Safety of Antipsychotic Medications and Mood Stabilizers During Pregnancy: A Systematic Review and Network Meta-analysis of Congenital Malformations and Prenatal Outcomes. [PDF]

CNS Drugs
Wang E, Liu Y, Wang Y, Han X, Zhou Y, Zhang L, Tang Y.   +6 more
europepmc   +1 more source

Potential of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Mitigating Metabolic Side Effects Associated With Clozapine or Olanzapine Therapy: A Literature Review. [PDF]

Cureus
Meftah A, Yoade B, Cowart C, Choi A, Popoola O, Afe O, Efremoff S, Ezema C, Johnson B, Lawrence J, Olupona T.   +10 more
europepmc   +1 more source

Comparison of Neurocognitive Effects of Blonanserin, Olanzapine, Aripiprazole, and Risperidone in Drug-Naïve First-Episode Schizophrenia. [PDF]

Neuropsychiatr Dis Treat
Hu W, Huang B, Guo X, Yin X, Wang X, Ji Y, Zheng Y, Gao T, Shi C, Yu X, Pu C.   +10 more
europepmc   +1 more source

An observational study on the effects of as-needed use of various antipsychotic drugs for agitation due to psychotic disorders. [PDF]

Int Clin Psychopharmacol
Hatta K, Morikawa F, Yamasaki S, Ishizuka T, Nakamura M, Hino K, Katayama S, Imai A, Fujita K, Sugiyama N, JAST study group.   +10 more
europepmc   +1 more source

Antipsychotic Drugs and the Risk of Diabetic Complications: A Systematic Review of Observational Studies. [PDF]

J Clin Med
Haddad N, Farhat N, Gravel CA, Chen Y, Momoli F, Mattison DR, Goguen J, Krewski D.   +7 more
europepmc   +1 more source

Three-week effect of amisulpride, aripiprazole, and olanzapine on gene expression in peripheral blood in individuals with schizophrenia spectrum disorders. [PDF]

Int J Neuropsychopharmacol
Torsvik A, Trentani A, Stokowy TK, Skrede S, Joa I, Klæbo Reitan SM, Rettenbacher M, Kroken RA, Johnsen E, Steen VM.   +9 more
europepmc   +1 more source

Learning Outcomes That Maximally Differentiate Psychiatric Treatments. [PDF]

Int J Methods Psychiatr Res
Strobl EV, Kim S.
europepmc   +1 more source

Efficacy and Safety of Olanzapine Long-acting Injection in Schizophrenia and Schizoaffective Disorder: A Systematic Review and Meta-analysis. [PDF]

Clin Psychopharmacol Neurosci
Joseph JT, Vishwanath R, Shenoy S.
europepmc   +1 more source

Concomitant Hypertriglyceridemia-Induced Pancreatitis and Diabetic Ketoacidosis in the Setting of Olanzapine Use: A Case Report. [PDF]

Clin Case Rep
Ingawale S, Pandey A, Varak P, Miskin V, Chandak V, Sharma P.   +5 more
europepmc   +1 more source

Cariprazine augmentation for negative symptoms of schizophrenia: a prospective analysis and literature review. [PDF]

Ther Adv Psychopharmacol
Okon-Rocha E, Taylor D.
europepmc   +1 more source